SC terms IMA prez's comments on top court in Patanjali case 'unacceptable'

'IMA president gave an interview on the eve of the hearing. Why on the eve of hearing?" the bench asked

Supreme Court, Manipur violence
Press Trust of India New Delhi
2 min read Last Updated : May 07 2024 | 6:52 PM IST

The Supreme Court on Tuesday termed as "very, very unacceptable" the statements made by Indian Medical Association (IMA) president R V Asokan targeting the apex court in a recent interview where he answered questions about Patanjali Ayurved's misleading advertisements case.

Expressing displeasure over Asokan's comments a day before the top court was slated to the hear the matter, a bench of Justices Hima Kohli and Ahsanuddin Amanullah sought his response on an application filed by Patanjali Ayurved Ltd.

Senior advocate Mukul Rohatgi, appearing for Patanjali, told the bench that they have filed an application urging the court to take judicial notice of the "wanton and unwarranted comments" made by the IMA president.
 

"This is a very serious issue. They are trying to divert the course of justice Your lordships asked one or two queries and see how they are reacting as if nobody can ask anything," Rohatgi said.

Rohatgi said at the last hearing, he had handed over to the court the transcript of the interview which was published in newspapers.

"You can't say you don't know," the bench told the IMA's counsel.

Later during the hearing, when senior advocate P S Patwalia appeared for the IMA, the bench asked him about the comments made by Asokan.

When Patwalia said it was "rather not very fortunate", the bench curtly told him, "You are very mild with your words".

"Your president gave an interview on the eve of the hearing. Why on the eve of hearing?" the bench asked.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :Patanjali AyurvedPatanjali Ayurved RamdevSupreme Courtmisleading advertisements

First Published: May 07 2024 | 6:52 PM IST

Next Story